在骨髓增殖性瘤中治疗状静脉血栓的抗凝药:系统性审查和元分析

Pavlina Chrysafi1, Kevin Barnum2, Genevieve M Gerhard3

  • 1Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts, USA. Electronic address: https://twitter.com/PavlinaChrysafi.

概括

患有骨髓增殖性瘤 (MPN) 和静脉血栓症 (SpVT) 的患者在服用抗凝药时面临出血和复发性血栓症的重大风险. 需要进一步的研究来优化这种患者群的治疗策略.